Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development and characterisation of a peptidergic N-and C-terminally stabilised mammalian NPY1R agonist which protects against diabetes induction
Ryan A. Lafferty, Neil Tanday, Peter R. Flatt, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2020) Vol. 1864, Iss. 5, pp. 129543-129543
Open Access | Times Cited: 14

Showing 14 citing articles:

Pancreatic polypeptide revisited: Potential therapeutic effects in obesity-diabetes
Wuyun Zhu, Neil Tanday, Peter R. Flatt, et al.
Peptides (2022) Vol. 160, pp. 170923-170923
Open Access | Times Cited: 26
Established and emerging roles peptide YY (PYY) and exploitation in obesity–diabetes
Ryan A. Lafferty, Peter R. Flatt, Nigel Irwin
Current Opinion in Endocrinology Diabetes and Obesity (2020) Vol. 28, Iss. 2, pp. 253-261
Open Access | Times Cited: 39
The role of gut–islet axis in pancreatic islet function and glucose homeostasis
Qi Chen, Yuanyuan Gao, Fangyu Li, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Positive Effects of NPY1 Receptor Activation on Islet Structure Are Driven by Pancreatic Alpha- and Beta-Cell Transdifferentiation in Diabetic Mice
Ryan A. Lafferty, Neil Tanday, R. Charlotte Moffett, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 21
Beneficial metabolic effects of recurrent periods of beta‐cell rest and stimulation using stable neuropeptide Y1 and glucagon‐like peptide‐1 receptor agonists
Neil Tanday, Ryan A. Lafferty, Peter R. Flatt, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 12, pp. 2353-2363
Open Access | Times Cited: 11
Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes
Chieh-Hsin Yang, Danise Ann-Onda, Xuzhu Lin, et al.
Molecular Metabolism (2021) Vol. 55, pp. 101413-101413
Open Access | Times Cited: 13
Development and characterisation of novel, enzymatically stable oxytocin analogues with beneficial antidiabetic effects in high fat fed mice
Shruti Mohan, Andrew McCloskey, Aine McKillop, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2020) Vol. 1865, Iss. 3, pp. 129811-129811
Open Access | Times Cited: 12
NPYR modulation: Potential for the next major advance in obesity and type 2 diabetes management?
Ryan A. Lafferty, Peter R. Flatt, Nigel Irwin
Peptides (2024) Vol. 179, pp. 171256-171256
Open Access | Times Cited: 1
Generation and characterisation of C-terminally stabilised PYY molecules with potential in vivo NPYR2 activity
Ryan A. Lafferty, Neil Tanday, Peter R. Flatt, et al.
Metabolism (2020) Vol. 111, pp. 154339-154339
Open Access | Times Cited: 9
Beneficial impact of Ac3IV, an AVP analogue acting specifically at V1a and V1b receptors, on diabetes islet morphology and transdifferentiation of alpha- and beta-cells
Shruti Mohan, Ryan A. Lafferty, Neil Tanday, et al.
PLoS ONE (2021) Vol. 16, Iss. 12, pp. e0261608-e0261608
Open Access | Times Cited: 7
Ac3IV, a V1a and V1b receptor selective vasopressin analogue, protects against hydrocortisone-induced changes in pancreatic islet cell lineage
Shruti Mohan, Ryan A. Lafferty, Peter R. Flatt, et al.
Peptides (2022) Vol. 152, pp. 170772-170772
Open Access | Times Cited: 3
Metabolic effects of combined glucagon receptor antagonism and glucagon-like peptide-1 receptor agonism in high fat fed mice
Zara J. Franklin, Ryan A. Lafferty, Peter R. Flatt, et al.
Biochimie (2022) Vol. 199, pp. 60-67
Open Access | Times Cited: 3
Pharmacology of Gut Hormone Mimetics for Obesity and Diabetes
Ryan A. Lafferty, Finbarr O’Harte, Nigel Irwin, et al.
Elsevier eBooks (2021), pp. 301-343
Closed Access | Times Cited: 1
Peptide Co-Agonists for Combined Activation of the APJ and GLP-1 Receptors with Insulinotropic and Satiety Actions Show Potential for Alleviation of Metabolic Dysfunction in Type 2 Diabetes
Finbarr O’Harte, Vadivel Parthsarathy, Sarah Craig, et al.
(2023), pp. 1-1
Open Access
Page 1

Scroll to top